StockNow
Calendar
Log in
U.S. Markets

Vertex Pharmaceuticals (VRTX) Q3 2026 (USD) Adj. EPS 4.76 (exp. 4.80), Revenue 3.44bln (exp. 3.42bln)

ORIGINAL · NewsquawkVertex Pharmaceuticals (VRTX) Q3 2026 (USD) Adj. EPS 4.76 (exp. 4.80), Revenue 3.44bln (exp. 3.42bln)Read originalHide original

Sees FY revenue USD 13.15bln-13.25bln (exp. 13.3bln)

StockNow breaking-news AI analysis

Vertex’s reported Q3 EPS was below expectations, revenue was above expectations, and its FY revenue outlook was below the stated expectation; detailed corroborating evidence was unavailable.

News detail

Sees FY revenue USD 13.15bln-13.25bln (exp. 13.3bln)

1 stocks
VRTXVertex Pharmaceuticals Inc$557.61Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Markets

Palantir (PLTR) Q3 2026 (USD): Adj. EPS 0.44 (exp. 0.41), Revenue 2.31bln (exp. 2.18bln); Adj. operating income 1.43bln (exp. 1.3bln)

PLTRGeopolitics

No new developments in message exchange with the US, reports Fars citing sources

U.S. Markets

Apple (AAPL) Q4 2026 (USD): EPS 2.10 (exp. 1.99), Revenue 114.5bln (exp. 113.4bln); Net income 30.7bln (exp. 29bln); Operating income 35.6bln (exp. 34.6bln); Operating expenses 19.2bln

AAPL